Mckesson Corp
NYSE:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
NYSE:MCK
Watchlist
Price: 808.8 USD -0.66% Market Closed
Market Cap: 99.8B USD

Intrinsic Value

The intrinsic value of one MCK stock under the Base Case scenario is 1 284.92 USD. Compared to the current market price of 808.8 USD, Mckesson Corp is Undervalued by 37%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MCK Intrinsic Value
1 284.92 USD
Undervaluation 37%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Mckesson Corp

What is Valuation History?
Ask AI Assistant
What other research platforms think about MCK?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is MCK valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Mckesson Corp.

Explain Valuation
Compare MCK to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

McKesson’s heavy reliance on large pharmaceutical manufacturers and payers could result in margin pressures if partners consolidate or aggressively negotiate prices, hurting profitability.

Potential disruptions to McKesson’s supply chain, particularly in generic drug procurement, risk creating unexpected shortages or higher costs that cannot be easily passed on to customers.

Regulatory scrutiny over pharmaceutical distribution practices, including opioid handling, may lead to costly legal settlements or additional compliance requirements, eroding earnings.

Bull Theses

The company’s massive distribution scale and long-standing relationships with healthcare providers position McKesson to weather competitive pressures and maintain stable margins.

McKesson’s strategic focus on technology solutions, such as advanced analytics and supply chain software, could unlock incremental revenue streams and reinforce customer loyalty.

Expanding specialty drug distribution, including oncology and specialty therapies, provides a higher-margin growth avenue that could meaningfully boost McKesson’s profitability over time.

Show More Less
How do you feel about MCK?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mckesson Corp

Current Assets 59.9B
Cash & Short-Term Investments 4B
Receivables 28.3B
Other Current Assets 27.6B
Non-Current Assets 24.3B
Long-Term Investments 119m
PP&E 4.6B
Intangibles 15.5B
Other Non-Current Assets 4B
Current Liabilities 68B
Accounts Payable 60.9B
Accrued Liabilities 5.3B
Other Current Liabilities 1.7B
Non-Current Liabilities 17.9B
Long-Term Debt 6B
Other Non-Current Liabilities 11.9B
Efficiency

Free Cash Flow Analysis
Mckesson Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mckesson Corp

Revenue
387.1B USD
Cost of Revenue
-373.7B USD
Gross Profit
13.4B USD
Operating Expenses
-8.3B USD
Operating Income
5.2B USD
Other Expenses
-1.2B USD
Net Income
4B USD
Fundamental Scores

MCK Profitability Score
Profitability Due Diligence

Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

43/100
Profitability
Score

Mckesson Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

MCK Solvency Score
Solvency Due Diligence

Mckesson Corp's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Positive Net Debt
Long-Term Solvency
66/100
Solvency
Score

Mckesson Corp's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MCK Price Targets Summary
Mckesson Corp

Wall Street analysts forecast MCK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCK is 937.87 USD with a low forecast of 647.65 USD and a high forecast of 1 050 USD.

Lowest
Price Target
647.65 USD
20% Downside
Average
Price Target
937.87 USD
16% Upside
Highest
Price Target
1 050 USD
30% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for MCK is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MCK Insider Trading
Buy and sell transactions by insiders

MCK News

Other Videos
What is the Intrinsic Value of one MCK stock?

The intrinsic value of one MCK stock under the Base Case scenario is 1 284.92 USD.

Is MCK stock undervalued or overvalued?

Compared to the current market price of 808.8 USD, Mckesson Corp is Undervalued by 37%.

Back to Top